Cargando…
Use of denosumab in recurrent chondroblastoma of the squamous temporal bone: a case report
Chondroblastoma is a rare, benign bone tumor that represents 1–2% of all primary bone tumors. Denosumab, a monoclonal antibody, has been demonstrated to inhibit the growth of giant cell tumors. We report a case of recurrent chondroblastoma of the squamous temporal bone that is currently suppressed w...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378851/ https://www.ncbi.nlm.nih.gov/pubmed/28396758 http://dx.doi.org/10.1002/ccr3.838 |